Bibliography
Filters: Author is Drummond, Michael [Clear All Filters]
Reimbursement of pharmaceuticals: reference pricing versus health technology assessment. Eur J Health Econ. 2011;12(3):263-71. Abstract
Assessing the added value of health technologies: reconciling different perspectives. Value Health. 2013;16(1 Suppl):S7-13. Abstract
The usefulness of the NHS Economic Evaluation Database to researchers undertaking technology assessment reviews. Int J Technol Assess Health Care. 2004;20(3):249-57. Abstract
How can the impact of health technology assessments be enhanced?. Permanand G, Figueras J, Lavis J, McDaid D, Mossialos E, editors. Copenhagen: WHO Regional Office for Europe; 2008. Abstract
Technology assessment in the German context. Eur J Health Econ. 2007;8 Suppl 1:S3.
The usefulness of the NHS Economic Evaluation Database to researchers undertaking technology assessment reviews. Int J Technol Assess Health Care. 2004;20(3):249-57. Abstract
Reimbursement of pharmaceuticals: reference pricing versus health technology assessment. Eur J Health Econ. 2011;12(3):263-71. Abstract
Technology assessment in the German context. Eur J Health Econ. 2007;8 Suppl 1:S3.
Assessing the added value of health technologies: reconciling different perspectives. Value Health. 2013;16(1 Suppl):S7-13. Abstract
Reimbursement of pharmaceuticals: reference pricing versus health technology assessment. Eur J Health Econ. 2011;12(3):263-71. Abstract
Assessing the added value of health technologies: reconciling different perspectives. Value Health. 2013;16(1 Suppl):S7-13. Abstract
Technology assessment in the German context. Eur J Health Econ. 2007;8 Suppl 1:S3.
Technology assessment in the German context. Eur J Health Econ. 2007;8 Suppl 1:S3.
Technology assessment in the German context. Eur J Health Econ. 2007;8 Suppl 1:S3.
Reimbursement of pharmaceuticals: reference pricing versus health technology assessment. Eur J Health Econ. 2011;12(3):263-71. Abstract
Assessing the added value of health technologies: reconciling different perspectives. Value Health. 2013;16(1 Suppl):S7-13. Abstract
Reimbursement of pharmaceuticals: reference pricing versus health technology assessment. Eur J Health Econ. 2011;12(3):263-71. Abstract
The usefulness of the NHS Economic Evaluation Database to researchers undertaking technology assessment reviews. Int J Technol Assess Health Care. 2004;20(3):249-57. Abstract
Assessing the added value of health technologies: reconciling different perspectives. Value Health. 2013;16(1 Suppl):S7-13. Abstract
Technology assessment in the German context. Eur J Health Econ. 2007;8 Suppl 1:S3.
Reimbursement of pharmaceuticals: reference pricing versus health technology assessment. Eur J Health Econ. 2011;12(3):263-71. Abstract
The usefulness of the NHS Economic Evaluation Database to researchers undertaking technology assessment reviews. Int J Technol Assess Health Care. 2004;20(3):249-57. Abstract
Assessing the added value of health technologies: reconciling different perspectives. Value Health. 2013;16(1 Suppl):S7-13. Abstract
How can the impact of health technology assessments be enhanced?. Permanand G, Figueras J, Lavis J, McDaid D, Mossialos E, editors. Copenhagen: WHO Regional Office for Europe; 2008. Abstract
Reimbursement of pharmaceuticals: reference pricing versus health technology assessment. Eur J Health Econ. 2011;12(3):263-71. Abstract